Transcriptional repressor REST drives lineage stage-specific chromatin compaction at


Journal

Science signaling
ISSN: 1937-9145
Titre abrégé: Sci Signal
Pays: United States
ID NLM: 101465400

Informations de publication

Date de publication:
22 01 2019
Historique:
entrez: 24 1 2019
pubmed: 24 1 2019
medline: 17 3 2020
Statut: epublish

Résumé

In medulloblastomas (MBs), the expression and activity of RE1-silencing transcription factor (REST) is increased in tumors driven by the sonic hedgehog (SHH) pathway, specifically the SHH-α (children 3 to 16 years) and SHH-β (infants) subgroups. Neuronal maturation is greater in SHH-β than SHH-α tumors, but both correlate with poor overall patient survival. We studied the contribution of REST to MB using a transgenic mouse model (

Identifiants

pubmed: 30670636
pii: 12/565/eaan8680
doi: 10.1126/scisignal.aan8680
pmc: PMC8939892
mid: NIHMS1025141
pii:
doi:

Substances chimiques

Chromatin 0
Hedgehog Proteins 0
Patched-1 Receptor 0
RE1-silencing transcription factor 0
Repressor Proteins 0
Proto-Oncogene Proteins c-akt EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : R01 CA185402
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS079715
Pays : United States
Organisme : NINDS NIH HHS
ID : R03 NS077021
Pays : United States

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Cancer Res. 2008 Mar 15;68(6):1768-76
pubmed: 18339857
Future Neurol. 2009;4(3):317-329
pubmed: 19885378
Neuron. 1999 Jan;22(1):103-14
pubmed: 10027293
Cancer Res. 2006 Jan 15;66(2):839-45
pubmed: 16424016
Acta Neuropathol Commun. 2013 Jul 11;1:35
pubmed: 24252690
PLoS Biol. 2008 Oct 28;6(10):e256
pubmed: 18959480
Mol Cancer Res. 2017 Aug;15(8):1073-1084
pubmed: 28483947
Am J Pathol. 1971 Apr;63(1):37-56
pubmed: 4323476
J Biol Chem. 2015 Oct 23;290(43):26088-102
pubmed: 26338712
Mol Cell Biol. 2006 Mar;26(5):1666-78
pubmed: 16478988
Cell Biosci. 2013 Oct 09;3(1):39
pubmed: 24172249
Cell. 1995 Mar 24;80(6):949-57
pubmed: 7697725
Cancer Cell. 2017 Jun 12;31(6):737-754.e6
pubmed: 28609654
Cancer Res. 2004 Nov 1;64(21):7794-800
pubmed: 15520185
Sci Rep. 2016 Jun 03;6:27012
pubmed: 27255663
Mol Cancer Ther. 2005 Mar;4(3):343-9
pubmed: 15767543
Cancer Cell. 2014 Dec 8;26(6):940-940.e1
pubmed: 25490452
Science. 1997 Aug 22;277(5329):1109-13
pubmed: 9262482
Nature. 2012 Feb 15;482(7386):529-33
pubmed: 22343890
Mol Cancer Ther. 2012 Aug;11(8):1713-1723
pubmed: 22848092
Curr Neurol Neurosci Rep. 2016 May;16(5):43
pubmed: 27021772
Trends Neurosci. 2011 Mar;34(3):134-42
pubmed: 21315459
Cancer Res. 2013 Dec 1;73(23):7034-42
pubmed: 24154871
Nucleic Acids Res. 2005 Jun 06;33(10):3211-23
pubmed: 15939934
Nat Protoc. 2013 Mar;8(3):539-54
pubmed: 23429716
Oncotarget. 2017 Jul 25;8(30):49869-49881
pubmed: 28562331
Nature. 2008 May 8;453(7192):223-7
pubmed: 18362916
Exp Neurol. 2014 Oct;260:69-73
pubmed: 23178582
BMC Genomics. 2015 May 14;16:380
pubmed: 25971704
Oncogene. 2016 Nov 3;35(44):5746-5758
pubmed: 27065321
J Neurooncol. 2007 Nov;85(2):159-70
pubmed: 17534580
Ann Neurosci. 2014 Jan;21(1):28-31
pubmed: 25206052
BMC Cancer. 2017 Jul 17;17(1):488
pubmed: 28716052
Oncogene. 2001 Jun 28;20(29):3857-68
pubmed: 11439349
Cancer Cell. 2008 Aug 12;14(2):135-45
pubmed: 18691548
Mol Cell Biol. 2006 May;26(9):3365-77
pubmed: 16611981
PLoS One. 2010 May 26;5(5):e10849
pubmed: 20520772
Oncogene. 2009 Apr 2;28(13):1605-15
pubmed: 19234491
Nature. 2016 Jan 21;529(7586):351-7
pubmed: 26760213
Cancer Res. 2001 Jan 15;61(2):513-6
pubmed: 11212243
Genes Dev. 2008 Feb 15;22(4):436-48
pubmed: 18281460
Brain Pathol. 2013 Mar;23(2):193-9
pubmed: 23432644
Sci Signal. 2018 Sep 11;11(547):
pubmed: 30206138
Cancer Cell. 2008 Aug 12;14(2):123-34
pubmed: 18691547
Mol Biol Cell. 2005 Dec;16(12):5630-8
pubmed: 16195345
Development. 2005 May;132(10):2425-39
pubmed: 15843415
Acta Neuropathol. 2012 Apr;123(4):473-84
pubmed: 22358457
Oncogene. 2013 Mar 28;32(13):1691-701
pubmed: 22665064
Curr Opin Neurobiol. 1995 Oct;5(5):566-71
pubmed: 8580707
Acta Neuropathol. 2012 Apr;123(4):465-72
pubmed: 22134537
Nat Cell Biol. 2010 Feb;12(2):132-42
pubmed: 20081843
Nature. 2008 Mar 20;452(7185):370-4
pubmed: 18354483
Mol Cell. 2007 Feb 9;25(3):473-81
pubmed: 17289593
Cancer Res. 2012 Oct 1;72(19):4944-53
pubmed: 22875024
J Neurosci. 2015 Nov 04;35(44):14872-84
pubmed: 26538656
Trends Cell Biol. 2013 Jun;23(6):289-95
pubmed: 23414932
J Exp Med. 2006 Aug 7;203(8):1867-73
pubmed: 16880261
Clin Cancer Res. 2006 May 15;12(10):3019-27
pubmed: 16707597
Cell Rep. 2016 Mar 29;14(12):2925-37
pubmed: 26997276
Cell Cycle. 2013 Jun 15;12(12):1964-77
pubmed: 23708518
Oncogene. 2006 Sep 7;25(40):5575-80
pubmed: 16636673
Genome Res. 2009 Jun;19(6):994-1005
pubmed: 19401398
Cell. 2005 May 20;121(4):645-657
pubmed: 15907476
Curr Mol Med. 2015;15(1):82-93
pubmed: 25601471
Cell Rep. 2014 Jan 16;6(1):168-181
pubmed: 24373970
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4505-10
pubmed: 16537363
Oncogene. 2015 Sep 3;34(36):4746-57
pubmed: 25531316
Nat Med. 2000 Jul;6(7):826-31
pubmed: 10888935
Cell Tissue Res. 2015 Jan;359(1):99-109
pubmed: 25092546
Development. 2003 Jan;130(1):15-28
pubmed: 12441288
Cell Cycle. 2010 Oct 1;9(19):4013-24
pubmed: 20935513
J Neurosci. 2011 Jun 29;31(26):9772-86
pubmed: 21715642
Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):E4325-34
pubmed: 24167280
Oncogene. 2004 Aug 12;23(36):6156-62
pubmed: 15195141
Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10458-63
pubmed: 15240883
PLoS Genet. 2010 Jun 10;6(6):e1000979
pubmed: 20548947
Nat Rev Genet. 2007 Jul;8(7):544-54
pubmed: 17572692
Mol Cell. 2010 Jan 15;37(1):46-56
pubmed: 20129054
Oncotarget. 2015 Dec 22;6(41):43326-41
pubmed: 26498146
Cancer Cell. 2018 Sep 10;34(3):379-395.e7
pubmed: 30205043

Auteurs

Tara H W Dobson (THW)

Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Rong-Hua Tao (RH)

Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Jyothishmathi Swaminathan (J)

Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Shinji Maegawa (S)

Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Shavali Shaik (S)

Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Javiera Bravo-Alegria (J)

Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Ajay Sharma (A)

Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Bridget Kennis (B)

Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Yanwen Yang (Y)

Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Keri Callegari (K)

Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Amanda R Haltom (AR)

Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Pete Taylor (P)

Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Mari Kogiso (M)

Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

Lin Qi (L)

Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

Soumen Khatua (S)

Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Stewart Goldman (S)

Department of Pediatrics, Northwestern University, Chicago, IL 60611, USA.

Rishi R Lulla (RR)

Department of Pediatrics, Northwestern University, Chicago, IL 60611, USA.

Jason Fangusaro (J)

Department of Pediatrics, Northwestern University, Chicago, IL 60611, USA.

Tobey J MacDonald (TJ)

Department of Pediatrics, Emory University, Atlanta, GA 30322, USA.

Xiao-Nan Li (XN)

Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
Department of Pediatrics, Northwestern University, Chicago, IL 60611, USA.

Cynthia Hawkins (C)

Department of Pathology, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.

Veena Rajaram (V)

Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA.

Vidya Gopalakrishnan (V)

Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. vgopalak@mdanderson.org.
Molecular and Cellular Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.
Brain Tumor Center, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.
Center for Cancer Epigenetics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.
The University of Texas MD Anderson Cancer Center-University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences, Houston, TX 77030, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH